His main research concerns Internal medicine, Renal function, Kidney disease, Endocrinology and Urology. Tom Greene frequently studies issues relating to Diabetes mellitus and Internal medicine. His work deals with themes such as Creatinine, Ramipril, Proteinuria and Disease, which intersect with Renal function.
His research in Kidney disease intersects with topics in Body mass index, Surgery, Cohort study, Cardiology and Intensive care medicine. The various areas that Tom Greene examines in his Endocrinology study include Gastroenterology and National Health and Nutrition Examination Survey. Tom Greene has researched Urology in several fields, including Blood urea nitrogen, Interquartile range, Nephropathy, Urinary system and Serum Creatinine Measurement.
Tom Greene mainly focuses on Internal medicine, Kidney disease, Renal function, Endocrinology and Surgery. His Internal medicine research is multidisciplinary, incorporating elements of Diabetes mellitus and Cardiology. His Kidney disease study also includes fields such as
His studies in Renal function integrate themes in fields like Creatinine, Proteinuria, Disease and Urology. His Endocrinology research incorporates elements of Gastroenterology and National Health and Nutrition Examination Survey. His Hemodialysis study incorporates themes from Urea, Dialysis and Confidence interval.
Tom Greene mostly deals with Internal medicine, Kidney disease, Renal function, Clinical trial and Randomized controlled trial. His Internal medicine study integrates concerns from other disciplines, such as Diabetes mellitus, Canagliflozin, Type 2 diabetes and Cardiology. Tom Greene conducts interdisciplinary study in the fields of Kidney disease and In patient through his research.
The Renal function study combines topics in areas such as Urology, Placebo, Clinical endpoint, Urinary system and Creatinine. He studies Cystatin C which is a part of Creatinine. His Randomized controlled trial research is multidisciplinary, relying on both Psychological intervention, Physical therapy and Comparative effectiveness research.
Kidney disease, Internal medicine, Renal function, Clinical trial and Diabetes mellitus are his primary areas of study. Tom Greene has included themes like Gastroenterology, Nephropathy, Confidence interval and Surrogate endpoint in his Kidney disease study. His Internal medicine research integrates issues from Dapagliflozin and Cardiology.
The concepts of his Renal function study are interwoven with issues in Creatinine, Intensive care medicine, Cohort and Urology. His Creatinine study focuses on Cystatin C in particular. Tom Greene interconnects Adverse effect, Randomized controlled trial and Disease in the investigation of issues within Clinical trial.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey;Lesley A. Stevens;Christopher H. Schmid;Yaping (Lucy) Zhang.
Annals of Internal Medicine (2009)
A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
Andrew S. Levey;Juan P. Bosch;Julia Breyer Lewis;Tom Greene.
Annals of Internal Medicine (1999)
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.
Andrew S. Levey;Josef Coresh;Tom Greene;Lesley A. Stevens.
Annals of Internal Medicine (2006)
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey
Josef Coresh;Brad C. Astor;Tom Greene;Garabed Eknoyan.
American Journal of Kidney Diseases (2003)
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Lesley A. Stevens;Josef Coresh;Tom Greene;Andrew S. Levey.
The New England Journal of Medicine (2006)
Estimating glomerular filtration rate from serum creatinine and cystatin C.
Lesley A. Inker;Christopher H. Schmid;Hocine Tighiouart;John H. Eckfeldt.
The New England Journal of Medicine (2012)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic;Vlado Perkovic;Meg J. Jardine;Meg J. Jardine;Bruce Neal;Bruce Neal;Bruce Neal;Severine Bompoint.
The New England Journal of Medicine (2019)
Low-level environmental lead exposure and children's intellectual function: an international pooled analysis.
Bruce P. Lanphear;Richard Hornung;Richard Hornung;Jane Khoury;Jane Khoury;Kimberly Yolton.
Environmental Health Perspectives (2005)
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
Garabed Eknoyan;Gerald J. Beck;Alfred K. Cheung;John T. Daugirdas.
The New England Journal of Medicine (2002)
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial
Jackson T. Wright;George Bakris;Tom Greene;Larry Y. Agodoa.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: